Shopping Cart 0
Cart Subtotal

Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies


Aurobindo Pharma Ltd (AUROPHARMA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system (CNS), cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, dietary supplements and fermentation based semi synthetic products. Aurobindo operates manufacturing facilities in India, the US, Brazil and Portugal; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.

Aurobindo Pharma Ltd Key Recent Developments

Jan 11,2019: Aurobindo Pharma to launch 147 drugs in different therapeutic segments in next 3 years

Dec 21,2018: Aurobindo Pharma to launch potassium chloride pills in US

Dec 18,2018: Suntuity delivers one of New Jersey's largest rooftop solar PV systems at Aurobindo Pharmaceuticals

Dec 02,2018: Aurobindo Pharma Expects First Biosimilar Approval In U.S. In 12-18 Months

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table Of Content


Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Aurobindo Pharma Ltd-Key Facts

Aurobindo Pharma Ltd-Key Employees

Aurobindo Pharma Ltd-Key Employee Biographies

Aurobindo Pharma Ltd-Major Products and Services

Aurobindo Pharma Ltd-History

Aurobindo Pharma Ltd-Company Statement

Aurobindo Pharma Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Aurobindo Pharma Ltd-Business Description

Business Segment: API Segment



Business Segment: ARV Formulations



Business Segment: EU Formulations



Business Segment: Growth Markets Formulations



Business Segment: US Formulations



Geographical Segment: Europe


Geographical Segment: India


Geographical Segment: Rest of the world


Geographical Segment: USA


R&D Overview

Aurobindo Pharma Ltd-SWOT Analysis

SWOT Analysis-Overview

Aurobindo Pharma Ltd-Strengths

Aurobindo Pharma Ltd-Weaknesses

Aurobindo Pharma Ltd-Opportunities

Aurobindo Pharma Ltd-Threats

Aurobindo Pharma Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Aurobindo Pharma Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 15, 2018: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU Share

Jul 17, 2018: Aurobindo to buy Apotex's businesses in five European countries

May 28, 2018: Aurobindo Pharma Q4 FY17-18 and FY17-18 Financial Results

Mar 05, 2018: Aurobindo Pharma Issued Clarification on US FDA Observations

Mar 05, 2018: Aurobindo Announces Inspection of Unit 4 by US FDA

Section 6-Appendix


Ratio Definitions

About GlobalData

Contact Us


List Of Figure

List of Figures

Aurobindo Pharma Ltd, Performance Chart (2014-2018)

Aurobindo Pharma Ltd, Ratio Charts

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

List Of Table

List of Tables

Aurobindo Pharma Ltd, Key Facts

Aurobindo Pharma Ltd, Key Employees

Aurobindo Pharma Ltd, Key Employee Biographies

Aurobindo Pharma Ltd, Major Products and Services

Aurobindo Pharma Ltd, History

Aurobindo Pharma Ltd, Other Locations

Aurobindo Pharma Ltd, Subsidiaries

Aurobindo Pharma Ltd, Joint Venture

Aurobindo Pharma Ltd, Key Competitors

Aurobindo Pharma Ltd, Ratios based on current share price

Aurobindo Pharma Ltd, Annual Ratios

Aurobindo Pharma Ltd, Annual Ratios (Cont...1)

Aurobindo Pharma Ltd, Annual Ratios (Cont...2)

Aurobindo Pharma Ltd, Interim Ratios

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Aurobindo Pharma Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Aurobindo Pharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Mylan NV

Lupin Ltd

Hikal Ltd

Emcure Pharmaceuticals Ltd

Dr. Reddy's Laboratories Ltd

Divi's Laboratories Ltd

Cipla Ltd

Cadila Healthcare Ltd